266 related articles for article (PubMed ID: 15140943)
1. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
2. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
3. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
Arnold S; Mira E; Muneer S; Korpanty G; Beck AW; Holloway SE; Mañes S; Brekken RA
Exp Biol Med (Maywood); 2008 Jul; 233(7):860-73. PubMed ID: 18445772
[TBL] [Abstract][Full Text] [Related]
7. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.
Brekken RA; Puolakkainen P; Graves DC; Workman G; Lubkin SR; Sage EH
J Clin Invest; 2003 Feb; 111(4):487-95. PubMed ID: 12588887
[TBL] [Abstract][Full Text] [Related]
8. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
Weaver MS; Sage EH; Yan Q
J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
[TBL] [Abstract][Full Text] [Related]
9. Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies.
Taverna D; Hynes RO
Cancer Res; 2001 Jul; 61(13):5255-61. PubMed ID: 11431367
[TBL] [Abstract][Full Text] [Related]
10. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
[TBL] [Abstract][Full Text] [Related]
11. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
12. Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
Arnold SA; Rivera LB; Miller AF; Carbon JG; Dineen SP; Xie Y; Castrillon DH; Sage EH; Puolakkainen P; Bradshaw AD; Brekken RA
Dis Model Mech; 2010; 3(1-2):57-72. PubMed ID: 20007485
[TBL] [Abstract][Full Text] [Related]
13. Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
Arnold SA; Rivera LB; Carbon JG; Toombs JE; Chang CL; Bradshaw AD; Brekken RA
PLoS One; 2012; 7(2):e31384. PubMed ID: 22348081
[TBL] [Abstract][Full Text] [Related]
14. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
15. Impaired capsule formation of tumors in periostin-null mice.
Shimazaki M; Kudo A
Biochem Biophys Res Commun; 2008 Mar; 367(4):736-42. PubMed ID: 18190787
[TBL] [Abstract][Full Text] [Related]
16. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
17. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
18. Normalization of the ovarian cancer microenvironment by SPARC.
Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
[TBL] [Abstract][Full Text] [Related]
19. Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule.
Yan Q; Perdue N; Blake D; Sage EH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4652-60. PubMed ID: 16303962
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.
Roland CL; Dineen SP; Toombs JE; Carbon JG; Smith CW; Brekken RA; Barnett CC
Exp Biol Med (Maywood); 2010 Feb; 235(2):263-70. PubMed ID: 20404043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
